Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Texas cities have some of the highest preterm birth rates in the US, highlighting maternal health crisis nationwide - 2ISS astronaut evacuation shouldn't interfere with upcoming Artemis 2 moon mission, NASA chief says
- 3At least 490 protesters killed in Iran, activists say
- 4Bullets in Luigi Mangione’s bag convinced police that he was UnitedHealthcare CEO killing suspect
- 5Looking for a great Thanksgiving side dish recipe? These are the crowd-pleasers the Yahoo team swears by.
- Reveal Less popular Authentic Realities You Didn't Learn in School
- Russia Creates New Military Branch Dedicated To Drone Warfare
- Wegmans recalls mixed nuts over salmonella contamination fears
- New hybrid mpox strain discovered in UK after US reports local spread
- Figure out How to Advance Space in Your Pre-assembled Home for Upgraded Usefulness
- Experience Is standing by: 10 Pleasant Setting up camp Areas to
- Going with Children: Tips for Tranquil Family Get-aways
- Understanding Preschool Projects: An Extensive Aide
- Birds at a college changed beak shapes during the pandemic. It might be a case of rapid evolution
